More than 20,000 inhalers returned since November 2023 through recycling pilot Exclusive: Since its launch in November 2023, 20,400 inhalers have been returned through the ‘Re-Hale’ scheme, which operates across 78 locations in East Kent.…
NHS rolls out new multiple sclerosis injection that cuts treatment time by 90% The NHS will be one of the first healthcare systems in the world to offer the new injection in the “coming weeks”.…
Joint guidance for asthma recommends replacing SABA with corticosteroid inhalers The draft guidance proposes the use of combined inhaled corticosteroid/formoterol inhalers over previously preferred short-acting beta agonists.…
Greener inhaler propellant is therapeutically equivalent to traditional alternatives, study results suggest Study authors reported overall bioequivalence between inhalers that use HFA-152a as a propellant and traditionally used devices with HFA-134a as a propellant.…
Combination treatment significantly increases chance of five-year Alzheimer’s survival, study results show Experts said the large study had found "small but significant effects" of combination treatment with donepezil and memantine in Alzheimer's disease.…
Combination treatment before surgery improves melanoma survival rates, study results show The 12-month event-free survival rate for patients with macroscopic stage III node-positive melanoma was 83.7% with the combination treatment, compared with 57.2% for adjuvant therapy alone.…
Best practice for medicines use in neonates An overview of pharmacokinetic and pharmacodynamic considerations when treating neonates, and the impacts on drug absorption, metabolism and elimination.…
Juvenile idiopathic arthritis: biologic disease modifying anti-rheumatic drugs Biologic disease modifying anti-rheumatic drugs have greatly changed the treatment and outcomes of juvenile idiopathic arthritis; there are many considerations for their use that pharmacists should be aware of.…
Case-based learning: ensuring safety of oral medicines for children An overview of the risks pharmacists should be aware of regarding oral medicines for children, including how these risks can be appropriately communicated to patients and parents or carers.…
Government and NHS England set up clinical reference group to deal with forthcoming shortage of Pabrinex A medicine supply notification advised NHS trusts to locate and consolidate their current Pabrinex stock, which is likely to be out of stock from August 2024 until September 2025.…
